—
C+
C+ The full Closelook — membership. Open the C+ overview

GE HealthCare Technologies Inc. (GEHC) — the peer cohort

As of 2026-09-24 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

GE HealthCare Technologies Inc. ranks 9 of 9 in its cohort on the Closelook composite (43/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
GEHC GE HealthCare Technologies Inc. 43 31 52 55 bear 26.3%
DXCM DexCom Inc 66 85 80 36 neutral 5.2%
GMED Globus Medical 58 21 64 58 bull 27.1%
SECT-B.ST Sectra AB (publ) 58 66 66 12 bear 21.5%
CEVI.ST CellaVision AB 55 69 69 31 bull 10.6%
SOON.SW Sonova H Ag 55 86 72 53 bull 2.4%
SYK Stryker Corporation 51 18 65 45 bear 30.6%
HALO Halozyme Therapeutics Inc 74 96 94 45 ok 1.4%
ARGX argenx NV ADR 64 74 73 27 ok 10.3%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-24

Quick answers

Who are GE HealthCare Technologies Inc.'s peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: DexCom Inc (DXCM), Globus Medical (GMED), Sectra AB (publ) (SECT-B.ST), CellaVision AB (CEVI.ST), Sonova H Ag (SOON.SW), Stryker Corporation (SYK), Halozyme Therapeutics Inc (HALO), argenx NV ADR (ARGX).

How does GEHC score against its peers?

GE HealthCare Technologies Inc.'s composite reads 43/100, ranking 9 of 9 in its cohort as of 2026-09-24; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.